Re: Request to Exclude Nomination Pursuant to Rule 14a-8(i)(8)

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Request to Exclude Nomination Pursuant to Rule 14a-8(i)(8)

posted on Sep 27, 2010 02:58PM

Sincerity works both ways, and I trust that you will accept the information provided as indicative of the futility in attempting to have the SEC rule against their own guidance.

As to the date change of the ASM, the first I knew of it was in reading the letter you provided.

If you sincerely wish to have a BoD more accountable to shareholders, I humbly suggest that you find four further candidates and propose an alternative slate for the ASM financial year ending May 31 2011.